The two-day event will take place on the 16-17th April at BMA House in London and will draw together world leaders in basic and clinical cannabinoid research alongside the most senior policy makers in the UK.
The validity of medicinal marijuana’s most celebrated benefit, pain reduction, has been called into question by a new review.
The researchers are urging health professionals to inform any patients at a high-risk of cardiovascular events, and perhaps even wean them off marijuana.
Professor David Nutt has never been afraid to stick his head above the parapet on the topic of drugs. His repeated calling-out of the failures of contemporary drug policy has seen him butt heads with academics and politicians alike. In this interview with Professor Nutt, we discuss pot, policy and the potential of psilocybin.
The newly formed Brussels-based industry body announces the appointment of Professor Trevor Jones, CBE, as its new chairman.